Works matching IS 21484279 AND DT 2022 AND VI 9 AND IP 2
Results: 12
Screening for Leishmania specific antibodies among patients with rheumatic diseases treated with biological therapy.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 114, doi. 10.5152/eurjrheum.2022.20105
- By:
- Publication type:
- Article
Sitagliptin-induced Achilles enthesopathy: Case report and literature review.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 111, doi. 10.5152/eujrheum.2022.21124
- By:
- Publication type:
- Article
Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 108, doi. 10.5152/eurjrheum.2022.21059
- By:
- Publication type:
- Article
Iatrogenic Cushing's syndrome from topical steroid use.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 106, doi. 10.5152/eurjrheum.2021.20154
- By:
- Publication type:
- Article
Pigmented villus fragments on synovial fluid examination.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 104, doi. 10.5152/eurjrheum.2021.20152
- By:
- Publication type:
- Article
How well are biologic and conventional DMARDs tolerated in psoriatic arthritis: A real world study.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 100, doi. 10.5152/eurjrheum.2021.21027
- By:
- Publication type:
- Article
Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 93, doi. 10.5152/eujrheum.2022.20258
- By:
- Publication type:
- Article
A comparison of rituximab with cyclophosphamide in terms of efficacy and complications as induction therapy for treating granulomatosis with polyangiitis: A three-center study.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 88, doi. 10.5152/eurjrheum.2022.21063
- By:
- Publication type:
- Article
A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 82, doi. 10.5152/eurjrheum.2022.21060
- By:
- Publication type:
- Article
Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 75, doi. 10.5152/eujrheum.2022.21067
- By:
- Publication type:
- Article
Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 68, doi. 10.5152/eurjrheum.2022.21099
- By:
- Publication type:
- Article
Next-Generation Sequencing Analysis of MVK, NLRP3, TNFRSF1A, and PSTPIP1 Genes in Patients without MEFV Gene Variation and Genotype-Phenotype Correlation.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 62, doi. 10.5152/eurjrheum.2022.21049
- By:
- Publication type:
- Article